Clean Energy Fuels Corp. (NASDAQ:CLNE) announced it will release financial results for the fourth quarter and year ended December 31, 2015 on Thursday, March 3, 2016 after market close, followed by an investor conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific). President and Chief Executive Officer of Clean Energy Andrew J. Littlefair and Chief Financial Officer Bob Vreeland will host the call.
Clean Energy Fuels Corp. (NASDAQ:CLNE) belongs to Utilities sector. Its net profit margin is -20.90% and weekly performance is 13.39%. On last trading day company shares ended up at $2.88.
On 22 February, Superior Energy Services, Inc. (NYSE:SPN) announced an adjusted net loss from continuing operations for the fourth quarter of 2015 of $61.3 million, or $0.41 per share, excluding special items, on revenue of $545.2 million. This compares to an adjusted net loss from continuing operations of $68.8 million, or $0.46 per share, excluding special items, for the third quarter of 2015, on revenue of $601.4 million, and net income from continuing operations of $73.4 million, or $0.48 per diluted share, for the fourth quarter of 2014, on revenue of $1,178.6 million.
Superior Energy Services, Inc. (NYSE:SPN) shares increased 5.54% in last trading session and ended the day at $10.28. SPN Gross Margin is 32.80% and its return on assets is -31.40%. Superior Energy Services, Inc. (NYSE:SPN) quarterly performance is -34.46%.
Kansas City Southern (NYSE:KSU) announced that effective February 26, 2016, David F. Garza, age 54, has joined its board of directors. “KCS is pleased that David has agreed to join the board of directors,” said Robert J. Druten, Chair of the Board of Directors of KCS. “The Board conducted a very thorough director search process throughout 2015, and David stood out to us as the best candidate to help guide the Company in the future.
On 29 February, Kansas City Southern (NYSE:KSU) shares decreased -2.65% and was closed at $81.71. KSU EPS growth in last 5 year was 21.40%. Kansas City Southern (NYSE:KSU) year to date (YTD) performance is 9.43%.
Exelixis (NASDAQ: EXEL) reported Q4 EPS of ($0.19), $0.03 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $9.94 million versus the consensus estimate of $8.16 million.
Exelixis, Inc. (NASDAQ:EXEL) ended the last trading day at $3.64. Company weekly volatility is calculated as 5.35% and price to cash ratio as 4.18. Exelixis, Inc. (NASDAQ:EXEL) showed a weekly performance of -10.78%.
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) reported that the results of a randomized, parallel-group, single-center, double-masked, vehicle-controlled Phase IIa clinical trial of topical ocular NS2 in subjects with induced allergic conjunctivitis demonstrated statistically significant activity of NS2 over vehicle in reducing ocular itching and tearing.
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) shares increased 31.30% in last trading session and ended the day at $4.90. ALDX return on assets is -44.90%. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) quarterly performance is -30.35%.